Market analysis shows the global obesity GLP-1 market was valued at about USD 8.21 billion in 2025 and is expected to reach roughly USD 66.57 billion by 2035, expanding at a CAGR of about 23% due to rising obesity rates and strong clinical effectiveness of GLP-1 drugs
These bags are ideal for keeping medications at a stable temperature for extended periods
View Zepbound Details Mounjaro (tirzepatide) Dual-action control originally approved for Type 2 Diabetes
Silveira SQ, da Silva LM, de Campos Vieira Abib A, de Moura DTH, de Moura EGH, Santos LB, et al
Other factors include injection site location (areas with more nerve endings, like the abdomen near the navel, may be more sensitive), skin hydration level, and muscle tension at the injection site
It conducts independent third-party testing for potency and performs compounding under FDA-approved chemicals